Pharmafile Logo
Pharmafocus logo
Advanced Search

China

Showing 15 posts of 258 posts found.

16792957331_d9572dbdf4_z

FDA expands list of valsartan recalls

August 9, 2018
Medical Communications China, FDA, US, heart medication, recall, valsartan

The US Food and Drug Administration (FDA) has expanded a list of products containing valsartan that are to be recalled. …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra

With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …

News
li_keqiang_chinese_and_foreign_press_conference

Chinese premier slams drug maker after vaccine scandal

July 23, 2018
Sales and Marketing CCP, China, biotech, scandal, vaccines

Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …

News
india_china_credit_pti

China opens market to Indian drugs with reduced tariffs

July 10, 2018
Manufacturing and Production, Sales and Marketing China, India, pharma

India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most …

News

Sanofi invests €66m in Chinese R&D hub

July 3, 2018
Manufacturing and Production China, Sanofi, chengdu, development, pharma, research

French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and …

News
opdivo_1_1

BMS’ Opdivo becomes first immuno-oncology agent available in China

June 18, 2018
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, China, NSCLC, lung cancer, oncology, opdivo, pharma

Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …

News
lilly_entrance_web

Eli Lilly partners with Chinese institution to advance the nation’s diabetes and CVD care

April 27, 2018
Medical Communications, Research and Development China, Eli Lilly, cardiovascular disorders, cvd, diabetes, pharma, type 2 diabetes

EIi Lilly has announced plans to partner up with China’s National Center for Cardiovascular Diseases (NCCD), the nation’s institution responsible …

News
mundipharma

Mundipharma signs Chinese licensing and distribution agreement with Grünenthal

January 16, 2018
Manufacturing and Production China, Grunenthal, Mundipharma, Tramal, pharma

US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on …

News
gilead-sciences

Gilead launches hep C drug Sovaldi in China at one-fifth of US price

November 29, 2017
Research and Development, Sales and Marketing China, Gilead, hepatitis C, pharma, sovaldi

Gilead has officially launched its hepatitis C drug Sovaldi (sofosbuvir) in the Chinese market, but with one major caveat: it …

News
800px-flag_of_the_peoples_republic_of_china

China to accelerate drug approvals with overseas trial data

October 9, 2017
Research and Development, Sales and Marketing China, drug approvals, pharma, pharmaceuticals

In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …

News
fosun_pharma

China’s Fosun Group grabs 74% stake in India’s Gland Pharma for $1.1 billion

September 18, 2017
Sales and Marketing China, Fosun Pharma, Gland Pharma, India, pharma, pharmaceuticals

Chinese conglomerate Fosun has agreed to acquire 74% of India’s Gland Pharma for $1.1 billion, sealing a previously unsuccessful deal …

News
distribution

China’s distribution changes force major US company out

July 25, 2017
Manufacturing and Production, Sales and Marketing Cardinal Health, China, biotech, distribution, drugs, pharma, pharmaceutical

Cardinal Health, one of the largest drug distributors in the US, is looking to sell on its network in China, …

News
pollution

Superbugs in the supply chain

May 26, 2017
Medical Communications Antibiotics, Changing Markets, China, IMAGE: Changing Markets, Superbugs

Bad Manufacturing Practices: Changing Markets examines China’s role in the antibiotics supply chain and the damaging pollution that results from …

News
shutterstock_274590824

China threatens prison time and death penalty to fight fraudulent trial data

May 12, 2017
Medical Communications, Research and Development, Sales and Marketing China

In a drastic move to help solve its notorious problem with fraudulent clinical trial data, China has introduced a policy …

News
china_wall

China proposes ways to speed up approval for imported drugs

March 20, 2017
Sales and Marketing China, imported drugs

It can currently take up to three or four years for a new drug to reach market in China, slowing …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026